In the context of blood neoplasms, LSD1 was found overexpressed in about 60% of acute myeloid leukemia cases (14, 15), where recent work has suggested that it contributes to leukemia development and propagation by imposing a myeloid maturation arrest and promoting proliferation of myeloid progenitors (16, 17). Here, KDM1A is linked to acute myeloid leukemia.